SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-24-000038
Filing Date
2024-05-02
Accepted
2024-05-02 16:32:18
Documents
58
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20240331.htm   iXBRL 10-Q 811453
2 EX-31.1 a2024-q110xqex311.htm EX-31.1 10772
3 EX-31.2 a2024-q110xqex312.htm EX-31.2 10847
4 EX-32.1 a2024-q110xqex321.htm EX-32.1 4973
5 EX-32.2 a2024-q110xqex322.htm EX-32.2 4972
11 PIPELINE abus-20240331_g1.jpg GRAPHIC 57830
  Complete submission text file 0001447028-24-000038.txt   4673666

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20240331.xsd EX-101.SCH 37311
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20240331_cal.xml EX-101.CAL 40684
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20240331_def.xml EX-101.DEF 172278
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20240331_lab.xml EX-101.LAB 387252
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20240331_pre.xml EX-101.PRE 278926
61 EXTRACTED XBRL INSTANCE DOCUMENT abus-20240331_htm.xml XML 581074
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 24909024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)